Recent studies by Harvard and MIT suggest a common biological foundation between schizophrenia and aging, with a focus on brain energy metabolism and mitochondrial dysfunction. Ketogenic therapy shows promise in improving metabolic and psychiatric health in bipolar and schizophrenia patients.
Two pivotal contributors—mitochondrial dysfunctions and epigenetic alterations—have emerged as significant players in the pathogenesis of mood disorders. #BrainEnergy https://t.co/4CRo7HFGvX
Research suggests a shared biological basis for cognitive impairment in schizophrenia and aging and points to new strategies for treating it https://t.co/7ipiY1qDiO
We know #keto therapy can send #bipolar into remission. But can we predict who might best respond? A new $6M RCT funded by @BaszuckiGroup's ReTHINK Bipolar program seeks to develop predictive biomarkers and further an understanding of the mechanisms of bipolar mania and… https://t.co/oqpE60eVeA
"Accumulating evidence indicates that aberrant brain energy metabolism associated with mitochondrial dysfunction and redox imbalance plays a critical role in schizophrenia and will be a promising target for future treatments." https://t.co/iWkEWTHn7P
NEW evidence continues to accumulate... Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial "dual metabolic–psychiatric benefits from ketogenic therapy." Thanks to @ShebaniMD @drericwestman et al! https://t.co/UvUWM9dDxS
“Harvard/MIT Study: Schizophrenia and Aging May Share a Common Biological Foundation” Article: https://t.co/JiuT1VS3X0